Which hedge funds own BLFS? BIOLIFE SOLUTIONS INC, Q2 2026 13F holders
23 tracked hedge funds disclosed a position in BLFS (BIOLIFE SOLUTIONS INC) in their Q2 2026 13F filings, worth $195.1m in total. The largest holder by portfolio weight is Casdin Capital, LLC at 6.6% of its book. 17 opened a new position this quarter: Roubaix Capital, LLC, Fox Run Management, L.L.C., Numerai GP LLC, Arrowpoint Investment Partners (Singapore) Pte. Ltd.. 6 exited: Diametric Capital, LP, EntryPoint Capital, LLC, Gsa Capital Partners LLP.
- 23
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 17
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 6
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $44.3m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $5.3m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $195m
- Combined value Sum of the holders' reported positions in the security.
- 1.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Diametric Capital, LP | 0.1% | $451k |
| EntryPoint Capital, LLC | 0.08% | $288k |
| Gsa Capital Partners LLP | 0.03% | $531k |
| Renaissance Technologies LLC | 0.01% | $4.0m |
| Freestone Grove Partners LP | 0.0% | $98.5k |
| Aquatic Capital Management LLC | 0.0% | $12.2k |
Ownership over time
Who discovered BLFS first? Beta
The run: Q2 2017 → Q1 2019, +649%
| Casdin Capital, LLC high conviction | Q4 2020 | – | +12.1 pts |
| Gagnon Advisors, LLC high conviction | Q3 2020 | – | +3.5 pts |
| Sandler Capital Management | Q3 2018 | – | +1.0 pts |
| Mirabella Financial Services LLP | Q1 2023 | – | 0.0 pts |
| Park West Asset Management LLC | Q1 2023 | – | −0.5 pts |
| Zweig-DiMenna Associates LLC | Q4 2021 | – | −0.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.